Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury.
Myocardial concentrations of C1q, a subunit of the first component of complement, were measured 5-120 minutes after ligation of a coronary artery in dogs injected with 125I-labeled human C1q and 131I-labeled human albumin. The 131I-labeled human serum albumin was used as a plasma protein marker. Ischemic regions of myocardium were defined by measuring regional myocardial blood flow by the reference sample method at intervals after coronary artery occlusion. Significant accumulations of 125I-C1q were demonstrated in the ischemic myocardium after coronary artery occlusions lasting 45 minutes. Some localization of C1q in ischemic myocardium was observed after a 15-minute occlusion, but the accumulations of C1q achieved in this case were not statistically significant. After coronary artery occlusions lasting greater than or equal to 45 minutes, left ventricular concentrations of C1q correlated reciprocally with regional myocardial blood flow. Moreover, high concentrations of C1q persisted in formerly ischemic segments after reperfusion. Radiolabeled neutrophils also accumulated selectively in ischemic segments relatively rich in C1q. It is suggested that complement activation may initiate the neutrophil-dependent portion of ischemic injury, delineated in recent years, that is associated with free radical release by phagocytic cells.
D000818:Animals; D003166:Complement Activating Enzymes / Q000378:metabolism*; D015922:Complement C1q; D003326:Coronary Circulation; D003327:Coronary Disease / Q000276:immunology*; D004285:Dogs; D006801:Humans; D007958:Leukocyte Count; D009206:Myocardium / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D012039:Regional Blood Flow; D012709:Serum Albumin / Q000378:metabolism
D012709:Serum Albumin; D015922:Complement C1q; D003166:Complement Activating Enzymes